Literature DB >> 30190955

Chemoembolization with DC Bead™ for the treatment of hepatocellular carcinoma: an update.

Katerina Malagari1, Emmanouil Emmanouil1, Maria Pomoni1, Dimitrios Kelekis1.   

Abstract

In this review, DC Bead™ for the treatment of hepatocellular carcinoma is discussed. The embolic device and its mechanism of action is described, focusing on the clinical application and the preclinical background. Guidelines for patient selection and management, along with technical considerations for the appropriate use are provided. Clinical details including local response, comparison with conventional chemoembolization and bland embolization, survival and safety issues are also discussed in detail.

Entities:  

Year:  2014        PMID： 30190955      PMCID： PMC6095310          DOI： 10.2217/hep.13.18

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


  31 in total

Review 1.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

Authors:  Andrew L Lewis; Matthew R Dreher
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

2.  Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.

Authors:  Katerina Malagari; Mary Pomoni; Themistoklis N Spyridopoulos; Hippokratis Moschouris; Alexis Kelekis; Spyros Dourakis; Efthymia Alexopoulou; John Koskinas; Michalis Angelopoulos; John Kornezos; Anastasia Pomoni; Savvas Tandeles; Athanasios Marinis; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-24       Impact factor: 2.740

3.  Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.

Authors:  Myeong Jun Song; Ho Jong Chun; Do Seon Song; Hee Yeon Kim; Sun Hong Yoo; Chung-Hwa Park; Si Hyun Bae; Jong Young Choi; U Im Chang; Jin Mo Yang; Hae Giu Lee; Seung Kew Yoon
Journal:  J Hepatol       Date:  2012-07-20       Impact factor: 25.083

4.  Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).

Authors:  Renumathy Dhanasekaran; David A Kooby; Charles A Staley; John S Kauh; Vinit Khanna; Hyun S Kim
Journal:  J Surg Oncol       Date:  2010-05-01       Impact factor: 3.454

5.  Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience.

Authors:  Hippocrates Moschouris; Katerina Malagari; Marianna Kalokairinou; Konstantinos Stamatiou; Athanasios Marinis; Marina Georgiou Papadaki
Journal:  Med Ultrason       Date:  2011-12       Impact factor: 1.611

6.  New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).

Authors:  Marco Biondi; Sabato Fusco; Andrew L Lewis; Paolo A Netti
Journal:  J Biomater Sci Polym Ed       Date:  2011-01-21       Impact factor: 3.517

7.  Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.

Authors:  Katerina Malagari; Mary Pomoni; Alexis Kelekis; Anastasia Pomoni; Spyros Dourakis; Themis Spyridopoulos; Hippokratis Moschouris; Emmanouil Emmanouil; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-24       Impact factor: 2.740

8.  Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

Authors:  Riccardo Lencioni; Laura Crocetti; Pasquale Petruzzi; Claudio Vignali; Elena Bozzi; Clotilde Della Pina; Irene Bargellini; Dania Cioni; Filippo Oliveri; Paolo De Simone; Carlo Bartolozzi; Maurizia Brunetto; Franco Filipponi
Journal:  J Hepatol       Date:  2008-04-24       Impact factor: 25.083

9.  Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.

Authors:  Katerina Malagari; Efthimia Alexopoulou; Katerina Chatzimichail; Brenda Hall; John Koskinas; Samantha Ryan; Eva Gallardo; Alexis Kelekis; Athanassios Gouliamos; Dimitrios Kelekis
Journal:  Abdom Imaging       Date:  2008 Sep-Oct

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.